Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Polichem, a member of the Almirall group since 2016, is a pharmaceutical company specializing in the development of innovative proprietary technologies for the treatment of dermatological and gynecological conditions. The company is best known for its patented Hydroxypropyl Chitosan (HPCH) technology, a water-soluble nail lacquer platform that has revolutionized the treatment of nail disorders like onychomycosis and nail psoriasis. Polichem's portfolio includes market-leading products such as Ciclopoli and Sililevo, which leverage this delivery system to enhance drug penetration through the nail plate. Beyond dermatology, the company maintains a strong presence in women's health and respiratory medicine, focusing on niche therapeutic areas with high unmet medical needs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Poli.